Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Oncologists' perspectives and practices on minimal residual disease testing in multiple myeloma

Dr Fathima Shehnaz Ayoobkhan - Internal Medicine Resident, Pontiac, USA
Oncologists' perspectives and practices on minimal residual disease testing in multiple myeloma ( Dr Fathima Shehnaz Ayoobkhan - Internal Medicine Resident, Pontiac, USA )
13 Jan 2025

The need for improved healthcare infrastructure for extranodal NK/T-cell lymphoma in Latin America

Dr Fabiola Valvert - INCAN, Guatemala City, Guatemala
The need for improved healthcare infrastructure for extranodal NK/T-cell lymphoma in Latin America ( Dr Fabiola Valvert - INCAN, Guatemala City, Guatemala )
13 Jan 2025

Insights into germline genetic screening of breast cancer patients

Dr Teresa Ramón y Cajal, Dr Marjanka Schmidt and Dr Seigo Nakamura
Insights into germline genetic screening of breast cancer patients ( Dr Teresa Ramón y Cajal, Dr Marjanka Schmidt and Dr Seigo Nakamura )
10 Jan 2025

Daratumumab and lenalidomide for frail patients with newly diagnosed multiple myeloma shows promising survival results

Prof Salomon Manier - Hospital Center University De Lille, Lille, France
Daratumumab and lenalidomide for frail patients with newly diagnosed multiple myeloma shows promising survival results ( Prof Salomon Manier - Hospital Center University De Lille, Lille, France )
9 Jan 2025

High-fibre dietary intervention in precursor plasma cell disorders improves biomarkers of disease, may delay progression to myeloma

Dr Urvi Shah - Memorial Sloan Kettering Cancer Center, New York, USA
High-fibre dietary intervention in precursor plasma cell disorders improves biomarkers of disease, may delay progression to myeloma ( Dr Urvi Shah - Memorial Sloan Kettering Cancer Center, New York, USA )
9 Jan 2025

Lack of benefit of auto-HCT in MCL patients in first complete remission with undetectable MRD

Dr Robert Dean - Cleveland Clinic Taussig Cancer Center, Cleveland, USA
Lack of benefit of auto-HCT in MCL patients in first complete remission with undetectable MRD ( Dr Robert Dean - Cleveland Clinic Taussig Cancer Center, Cleveland, USA )
9 Jan 2025

SABCS 2024: Highlights in breast cancer genomic testing

Prof Matteo Lambertini and Prof Virginia Kaklamani
SABCS 2024: Highlights in breast cancer genomic testing ( Prof Matteo Lambertini and Prof Virginia Kaklamani )
23 Dec 2024

KRdc as induction therapy shows improved OS for NDMM patients

Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK
KRdc as induction therapy shows improved OS for NDMM patients ( Dr Charlotte Pawlyn - Institute of Cancer Research, London, UK )
20 Dec 2024

Epcoritamab monotherapy is well tolerated and efficacious in patients with r/r CLL

Dr Alexey Danilov - City of Hope National Medical Center, Los Angeles, USA
Epcoritamab monotherapy is well tolerated and efficacious in patients with r/r CLL ( Dr Alexey Danilov - City of Hope National Medical Center, Los Angeles, USA )
20 Dec 2024

Targeted therapies associated with increased risk for and incidence of thrombosis in the treatment of breast cancer

Dr James Martin - Cleveland Clinic, Cleveland, USA
Targeted therapies associated with increased risk for and incidence of thrombosis in the treatment of breast cancer ( Dr James Martin - Cleveland Clinic, Cleveland, USA )
20 Dec 2024

Patients with early-stage, HR+/HER2-negative BC may benefit from adjuvant T-AC therapy more than from TC

Dr Nan Chen - The University of Chicago, Chicago, USA
Patients with early-stage, HR+/HER2-negative BC may benefit from adjuvant T-AC therapy more than from TC ( Dr Nan Chen - The University of Chicago, Chicago, USA )
19 Dec 2024

Postmastectomy radiotherapy in 'intermediate-risk' breast cancer does not impact overall survival

Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK
Postmastectomy radiotherapy in 'intermediate-risk' breast cancer does not impact overall survival ( Prof Ian Kunkler - University of Edinburgh, Edinburgh, UK )
19 Dec 2024